Investment in Viking Therapeutics, Inc. (Tables)

9 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Equity Method Investments

December 31, 2014 Viking's assets and liabilities which were consolidated for the period shown were as follows (in thousands):

	December 31, 2014
Cash and cash equivalents	$	756
Other current assets	18
Capitalized IPO expenses	2,268
Total current assets	$	3,042
Other assets	$	1
Total assets	$	3,043
Accounts payable	$	2,211
Accrued liabilities	77
Current portion of notes payable	334
Total current liabilities	$	2,622
Long-term portion of notes payable	2,331
Total liabilities	$	4,953